Italy hosts several internationally recognized centers for hereditary kidney disorders like polycystic kidney disease (PKD). These hospitals include JCI-accredited facilities and ERKNet Reference Centers specializing in rare renal diseases. Leading institutions in Rome, Milan, and Bologna provide advanced genetic testing and multidisciplinary management for autosomal dominant polycystic kidney disease.
- Ospedale San Carlo di Nancy: This Rome-based hospital maintains JCI accreditation and specializes in minimally invasive renal procedures.
- San Raffaele Hospital: A Milan center with ISO-accredited nephrology services ranked among the world best hospitals.
- Policlinico S.Orsola-Malpighi: An ERKNet Reference Center in Bologna dedicated to autosomal dominant polycystic kidney disease.
- Hospital of the Vanvitelli University: This Naples facility uses next-generation sequencing for complex hereditary kidney disorder diagnosis.
Bookimed Expert Insight: Italian centers like Ospedale San Carlo di Nancy handle high patient volumes, seeing 14,000 patients annually. Dr. Alessandro Calarco at this facility holds a patent for percutaneous kidney surgery instruments. This clinical scale often leads to faster access to specialized urological surgeons compared to general hospitals. For patients with PKD-related stones or structural issues, looking for surgeons with international board certifications in Rome or Milan is a reliable quality signal.
Patient Consensus: Patients note that major hospitals in Milan and Rome excel in transplant outcomes and immunology for advanced kidney disease. However, they suggest confirming genetic testing timelines early, as waiting lists for specialized molecular diagnosis can sometimes reach several months.